Skip to main content
. 2023 Nov 30;109(5):1460–1468. doi: 10.3324/haematol.2023.284453

Figure 2.

Figure 2.

Toxicity and response rates of patients with on-time (N=200) and delayed (N=40) cell infusion. (A) Toxicity of patients with on-time and delayed cell infusion. (B) Response rates of patients with on-time and delayed cell infusion. CRS: cytokine release syndrome; ICANS: immune effector cell-associated neurotoxicity syndrome; ORR: overall response rate; CR: complete response; **P<0.01